Status:
COMPLETED
The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery
Lead Sponsor:
Shanghai Tong Ren Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have...
Eligibility Criteria
Inclusion
- age \> 18 years,
- confirmed diagnosis of primary CRC,
- preoperative tumor stage of cT1 to cT4, N-/+, M0 as determined by contrast-enhanced computed tomography (CT),
- no distant metastasis, -American Society of Anesthesiologists(ASA)Physical Status Classification score of 1, 2, or 3-
Exclusion
- history of previous colorectal surgery, emergent surgery, or palliative resection;
- pregnancy or breastfeeding;
- allergy or history of an adverse reaction to ICG; and
- severe mental disorder.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT06508541
Start Date
July 15 2024
End Date
October 1 2024
Last Update
December 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Tongren Hospital
Changning, Shanghai Municipality, China, 200336